[eu]cite

Home Health & Pharmaceuticals In Vitro Diagnostic Medical Devices Regulation

Chapter VII · POST-MARKET SURVEILLANCE, VIGILANCE AND MARKET SURVEILLANCE  ›  Section 2 · Vigilance › Article 85

Analysis of vigilance data

The Commission shall, in collaboration with the Member States, put in place systems and processes to actively monitor the data available in the electronic system referred to in Article 87, in order to identify trends, patterns or signals in the data that may reveal new risks or safety concerns.

Where a previously unknown risk is identified or the frequency of an anticipated risk significantly and adversely changes the benefit-risk determination, the competent authority or, where appropriate, the coordinating competent authority shall inform the manufacturer, or where applicable the authorised representative, which shall then take the necessary corrective actions.

also move between articles